Evidence map›Paper›PMID 35630829›Full record

ArticleMolecules (Basel, Switzerland)2022

Synthesis and Biological Evaluation of 5'-

Hitesh K Agarwal, Bhupender S Chhikara, Guofeng Ye, Sitaram Bhavaraju, Ajay Dixit, Anil Kumar, Gustavo F Doncel, Keykavous Parang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Hitesh K AgarwalDepartment of Pharmaceutical Sciences, School of Pharmacy, South University, 709 Mall Boulevard, Savannah, GA 31406, USA.
Bhupender S ChhikaraDepartment of Biomedical and Pharmaceutical Sciences, School of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
Guofeng YeDepartment of Biomedical and Pharmaceutical Sciences, School of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
Sitaram BhavarajuDepartment of Biomedical and Pharmaceutical Sciences, School of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.ORCID 0000-0001-9551-8846
Ajay DixitDepartment of Biomedical and Pharmaceutical Sciences, School of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.
Anil KumarDepartment of Biomedical and Pharmaceutical Sciences, School of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.ORCID 0000-0003-4699-3178
Gustavo F DoncelCONRAD, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA 23507, USA.
Keykavous ParangDepartment of Biomedical and Pharmaceutical Sciences, School of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.ORCID 0000-0001-8600-0893
University of Rhode Island · USEastern Virginia Medical School · USTarget (United States) · US

Funding

CONRAD MSA-03-367
6 · The paper itself

Abstract

A number of 5′-O-fatty acyl derivatives of 3′-fluoro-2′,3′-dideoxythymidine (FLT, 1) were synthesized. These conjugates were evaluated for their potential as topical microbicides with anti-HIV activity against cell-free (X4 and R5), cell-associated, and multidrug-resistant viruses. Compared to FLT and 3′-azido-2′,3′-dideoxythymidine (AZT), 5′-O-(12-azidododecanoyl) (5), 5′-O-myristoyl (6), and 5′-O-(12-thioethyldodecanoyl) (8) derivatives of FLT were found to be more active against both cell-free viruses (lymphocytotropic and monocytotropic strains) with EC50 values of 0.4 μM, 1.1 μM, and <0.2 μM, respectively, as well as cell-associated virus with EC50 values of 12.6, 6.4, and 2.3 μM, respectively. Conjugates 5, 6, and 8 exhibited >4 and >30 times better antiviral index than FLT and AZT, respectively. Conjugates 5 and 8 were significantly more potent than FLT against many multidrug-resistant strains. A comparison of the anti-HIV activity with the corresponding non-hydrolyzable ether conjugates suggested that ester hydrolysis to FLT and fatty acids is critical to enable anti-HIV activity. Cellular uptake studies were conducted using fluorescent derivatives of FLT attached with 5(6)-carboxyfluorescein through either β-alanine (23) or 12-aminododecanoic acid (24) spacers. The lipophilic fluorescent analog with a long chain (24) showed more than 12 times higher cellular uptake profile than the fluorescent analog with a short chain (23). These studies further confirmed that the attachment of fatty acids improved the cellular uptake of nucleoside conjugates. In addition, 5, 6, and 8 were the least cytotoxic and did not alter vaginal cell and sperm viability compared to the positive control, a commercial topical spermicide (N-9), which significantly decreased sperm and vaginal cell viability inducing the generation of proinflammatory cytokines.

Indexed as

Anti-HIV AgentsHIV-1Cell LineDideoxynucleosidesEstersFatty AcidsalovudineAnti-HIV AgentsDideoxynucleosidesEstersFatty Acids3′-fluoro-2′,3′-dideoxythymidineanti-HIVcellular uptakecytotoxicityfatty acidsmultidrug-resistantproinflammatory cytokine

Identifiers

PMID35630829
PMCPMC9143043
OpenAlexW4281396737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.